L Vávrová Selected Research

Insulin Resistance

1/2012	Paraoxonase-1 (PON1) status in pancreatic cancer: relation to clinical parameters.
1/2009	[Features of metabolic syndrome in patients with depressive disorder].
1/2007	[Composition of the nonesterified fatty acids and lipid peroxidation in metabolic syndrome].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L Vávrová Research Topics

Disease

3	Insulin Resistance 01/2012 - 01/2007
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2009 - 01/2007
1	Necrosis 01/2014
1	Neoplasms (Cancer) 01/2012
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2012
1	Depressive Disorder (Melancholia) 01/2009

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2014 - 01/2012
2	oxidized low density lipoproteinIBA 01/2009 - 01/2007
1	CatalaseIBA 01/2014
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2014
1	arylesteraseIBA 01/2012
1	Aryldialkylphosphatase (Paraoxonase)IBA 01/2012
1	Triglycerides (Triacylglycerol)IBA 01/2009
1	Insulin (Novolin)FDA Link 01/2009
1	Glucose (Dextrose)FDA LinkGeneric 01/2009
1	C-PeptideIBA 01/2009
1	LipidsIBA 01/2007
1	Nonesterified Fatty Acids (NEFA)IBA 01/2007
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2007
1	Lipoproteins (Lipoprotein)IBA 01/2007